Charlotte Trefzer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charlotte Trefzer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Helmut Friess
Research Group MITI, TUM University Hospital, Technical University of Munich, TUM School of Medicine and Health, Munich, Germany
1 shared publication - Kamacay Cira
Klinik und Poliklinik für Chirurgie, TUM Klinikum, Rechts der Isar, TUM School of Medicine and Health, Technische Universität München, München, Deutschland
1 shared publication - Marc E. Martignoni
Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany
1 shared publication - Philipp-Alexander Neumann
Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany
1 shared publication - Stefan Reischl
Department of Diagnostic and Interventional Radiology, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany
1 shared publication - Tara Catharina Mueller
Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany
1 shared publication
Latest Publications
- Open Access
- 15 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (11) , 8050-8059
Low HS-Omega-3 index as a predictor of severe postoperative complications in abdominal surgery: a prospective observational study
Background: Omega-3 supplementation may reduce postoperative complications, but variability in formulations and lack of standardized monitoring limit its use. The HS-Omega-3 Index® offers a standardized measure of omega-3 status, but its role in surgical outcomes remains unexamined. This pilot prospective observational study investigated the association between preoperative HS-Omega-3 Index® and postoperative complications in patients undergoing major gastrointestinal or hepatobiliary surgeries, adopting a broad approach to assess its relevance. Method: This study included 269 patients undergoing elective gastrointestinal or hepatobiliary surgery between November 2020 and February 2023, excluding those receiving preoperative parenteral nutrition and other predefined criteria. Preoperative HS-Omega-3 Index® levels were measured and correlated with postoperative complications using the Clavien–Dindo (CD) classification. Logistic regression analysis, adjusted for confounders such as age, smoking status, sarcopenia, and visceral obesity, assessed the association between the HS-Omega-3 Index® and severe complications (CD≥3). Results: The HS-Omega-3 Index® was OR ], 0.72; P = 0.037). Conclusion: A reduced HS-Omega-3 Index® was highly prevalent in patients undergoing major abdominal surgery and was significantly associated with an increased risk of severe postoperative complications. These findings support the potential utility of the HS-Omega-3 Index® as a preoperative biomarker for risk stratification and for targeted prehabilitation strategies. Further studies are needed to confirm its impact on surgical outcomes.
- 15 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (11) , 8050-8059
Open AccessLow HS-Omega-3 index as a predictor of severe postoperative complications in abdominal surgery: a prospective observational study
Background: Omega-3 supplementation may reduce postoperative complications, but variability in formulations and lack of standardized monitoring limit its use. The HS-Omega-3 Index® offers a standardized measure of omega-3 status, but its role in surgical outcomes remains unexamined. This pilot prospective observational study investigated the association between preoperative HS-Omega-3 Index® and postoperative complications in patients undergoing major gastrointestinal or hepatobiliary surgeries, adopting a broad approach to assess its relevance. Method: This study included 269 patients undergoing elective gastrointestinal or hepatobiliary surgery between November 2020 and February 2023, excluding those receiving preoperative parenteral nutrition and other predefined criteria. Preoperative HS-Omega-3 Index® levels were measured and correlated with postoperative complications using the Clavien–Dindo (CD) classification. Logistic regression analysis, adjusted for confounders such as age, smoking status, sarcopenia, and visceral obesity, assessed the association between the HS-Omega-3 Index® and severe complications (CD≥3). Results: The HS-Omega-3 Index® was OR ], 0.72; P = 0.037). Conclusion: A reduced HS-Omega-3 Index® was highly prevalent in patients undergoing major abdominal surgery and was significantly associated with an increased risk of severe postoperative complications. These findings support the potential utility of the HS-Omega-3 Index® as a preoperative biomarker for risk stratification and for targeted prehabilitation strategies. Further studies are needed to confirm its impact on surgical outcomes.